Center for Studies in Demography and Ecology

NIH Funding Opportunities & Notices

Posted: 2/12/2018 (Funding)

NIH Guide for Grants and Contracts
February 9, 2018

Notices
Requests for Applications
Program Announcements
  • Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
    (PA-18-629)
    National Cancer Institute
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • NIBIB Exploratory Clinical Trials for Small Business (R44 Clinical Trial Required)
    (PA-18-631)
    National Institute of Biomedical Imaging and Bioengineering
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization.
  • NIDA Small Research Grant Program (R03 Clinical Trial Required)
    (PA-18-634)
    National Institute on Drug Abuse
    Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • NEI Academic Research Enhancement Award for Mechanistic and Minimal Risk Human Subjects’ Research (R15 Clinical Trial Optional)
    (PA-18-635)
    National Eye Institute
    Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is June 25, 2018.
  • NIMH Administrative Supplement Program to Enable Continuity of Research Experiences of MD/PhDs during Clinical Training (Admin Supp Clinical Trial Optional)
    (PA-18-642)
    National Institute of Mental Health
    Application Receipt Date(s): NIMH accepts and reviews applications on a continuous basis until April 1 of each fiscal year. Applications received after April 1 will be considered for funding in the next fiscal year. Earlier submission is strongly encouraged. Applications for FY 18 funds should be submitted no later than April 1, 2018. Applications for FY 19 funds should be submitted no later than April 1, 2019. Applications for FY 20 funds should be submitted no later than April 1, 2020 Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Supplements to Advance Research (STAR) from Projects to Programs (Admin Supp Clinical Trial Optional)
    (PA-18-647)
    National Institute on Alcohol Abuse and Alcoholism
    Application Receipt Date(s): July 1, 2018; March 1, 2019, July 1, 2019, March 1 2020, July 1, 2020, March 1, 2021 by 5:00 PM local time of applicant organization.
  • NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
    (PA-18-648)
    National Institutes of Health
    National Center for Advancing Translational Sciences
    National Center for Complementary and Integrative Health
    National Cancer Institute
    National Eye Institute
    National Human Genome Research Institute
    National Heart, Lung, and Blood Institute
    National Institute on Aging
    National Institute on Alcohol Abuse and Alcoholism
    National Institute of Allergy and Infectious Diseases
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute on Drug Abuse
    National Institute on Deafness and Other Communication Disorders
    National Institute of Dental and Craniofacial Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Institute of Environmental Health Sciences
    National Institute of General Medical Sciences
    National Institute on Minority Health and Health Disparities
    National Institute of Neurological Disorders and Stroke
    National Library of Medicine
    Office of the Director, NIH
    Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
    Office of Strategic Coordination (Common Fund)
    Office of Strategic Coordination (Common Fund)
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
    (PAR-18-628)
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization.
  • Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)
    (PAR-18-630)
    National Institute of Allergy and Infectious Diseases
    National Institute on Aging
    National Institute of General Medical Sciences
    Application Receipt Date(s): April 10, 2018; December 7, 2018; March 7, 2019; December 7, 2019 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required)
    (PAR-18-632)
    National Institute of Allergy and Infectious Diseases
    Application Receipt Date(s): May 14, 2018; September 13, 2018; January 14, 2019; May 13, 2019; September 13, 2019; January 13, 2020; May 13, 2020; September 14, 2020; January 13, 2021, by 5:00 PM local time of applicant organization.
  • NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
    (PAR-18-633)
    National Institute of Allergy and Infectious Diseases
    Application Receipt Date(s): May 14, 2018; September 13, 2018; January 14, 2019; May 13, 2019; September 13, 2019; January 13, 2020; May 13, 2020; September 14, 2020; January 13, 2021), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Innovative Approaches to Studying Cancer Communication in the New Media Environment (R01 – Clinical Trial Optional)
    (PAR-18-638)
    National Cancer Institute
    Application Receipt Date(s): June 13, 2018; October 11, 2018, June 13, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Innovative Approaches to Studying Cancer Communication in the New Media Environment (R21 – Clinical Trial Optional)
    (PAR-18-639)
    National Cancer Institute
    Application Receipt Date(s): June 13, 2018; October 11, 2018, June 13, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Perception and Cognition Research to Inform Cancer Image Interpretation (R01 Clinical Trial Optional)
    (PAR-18-640)
    National Cancer Institute
    National Institute of Biomedical Imaging and Bioengineering
    Application Receipt Date(s): May 30, 2018; September 26, 2018; May 30, 2019; September 26, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Perception and Cognition Research to Inform Cancer Image Interpretation (R21 Clinical Trial Optional)
    (PAR-18-641)
    National Cancer Institute
    National Institute of Biomedical Imaging and Bioengineering
    Application Receipt Date(s): May 30, 2018; September 26, 2018; May 30, 2019; September 26, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • NHLBI Clinical Ancillary Studies (R01 – Clinical Trial Optional)
    (PAR-18-643)
    National Heart, Lung, and Blood Institute
    Application Receipt Date(s): April 30, 2018, August 24, 2018, December 18, 2018, April 30, 2019, August 24, 2019, December 18, 2019, April 30, 2020, August 24, 2020, and December 18, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 – Clinical Trial Optional)
    (PAR-18-644)
    National Institute on Aging
    National Cancer Institute
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard due date for resubmission and revision applications is March 16, 2018. The first standard due date for new applications is June 16, 2018.
  • Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 – Clinical Trial Optional)
    (PAR-18-645)
    National Institute on Aging
    National Cancer Institute
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard due date for resubmission and revision applications is March 16, 2018. The first standard due date for new applications is June 16, 2018.
  • Opportunities for Collaborative Research at the NIH Clinical Center (U01 – Clinical Trial Optional)
    (PAR-18-646)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Center for Complementary and Integrative Health
    National Cancer Institute
    National Eye Institute
    National Human Genome Research Institute
    National Heart, Lung, and Blood Institute
    National Institute on Alcohol Abuse and Alcoholism
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    National Institute of Biomedical Imaging and Bioengineering
    National Institute on Drug Abuse
    National Institute on Deafness and Other Communication Disorders
    National Institute of Dental and Craniofacial Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Institute of Mental Health
    National Institute of Neurological Disorders and Stroke
    Office of Dietary Supplements
    Office of Research on Women’s Health
    Application Receipt Date(s): April 11, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Human-Animal Interaction (HAI) Research (R03 – Clinical Trial Optional)
    (PAR-18-649)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    Application Receipt Date(s): March 30, 2018, March 30, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Human-Animal Interaction (HAI) Research (R21 – Clinical Trial Optional)
    (PAR-18-650)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    Application Receipt Date(s): March 30, 2018, March 30, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

 

 

Read Full Article